“Obesity is the No. 1 health problem in the United States because it negatively affects our population’s health more than any other condition,” said Kaiser Permanente Washington Health Research Institute Senior Investigator David Arterburn, MD, MPH. Kaiser Permanente Washington researchers are doing practical research to learn how doctors, patients, families, employers, and policymakers can best work together to prevent and treat obesity.
“We’re focusing on 3 ways to halt the obesity epidemic,” said Senior Investigator Dori Rosenberg, PhD, MPH. “We’re helping to change obesity-promoting environments, bringing evidence-based prevention and treatment programs into health care systems, and helping people develop lifelong healthy diet and activity habits.”
Kaiser Permanente Washington obesity research areas include:
“Obesity is caused by many factors, so at Kaiser Permanente Washington, we’re working on many levels,” said Paula Lozano, MD, MPH, a senior investigator and Kaiser Permanente Washington’s senior associate medical director for research and translation. “We’re improving health care to help people who are obese now. But since obesity is a societal problem, we’re also studying how to change our homes and workplaces and neighborhoods to create more healthy environments.”
Crawford CL, Hansell LD, Hsu CW, Mogk J, Paz SR, Moore DD, Macias M, Bhakta BB, Ellis D, Lopez C, Jackson T, Borruso A, Graves R, Corralejo V, Gray MF, Young DR, Drewnowski A, Lewis KH, Coleman KJ Beyond the Scale: Patient Perceptions and Experiences of Bariatric Surgery Support-A Qualitative Analysis of the BELONG II Study 2026 Aug;16(4):e70093. doi: 10.1111/cob.70093. PubMed
Haneuse S, Benz L, Smith VA, Arterburn D, Maceijewski ML Long-term cardiovascular outcomes following bariatric surgery: Reconciling seemingly conflicting evidence 2026 Jul;37(4):467-475 doi:10.1097/EDE.0000000000001952. doi: 10.1097/EDE.0000000000001952. Epub 2026-01-21. PubMed
Yang J, Gu B, Pillai H, Lii J, Cronkite D, Marsolo KA, Desai RJ Using Natural Language Processing of Clinical Notes to Supplement Structured Electronic Health Record Data for Phenotyping Smoking and Obesity in a Healthcare System 2026 Jul;35(7):e70415. doi: 10.1002/pds.70415. PubMed
Curtis LH, Arterburn D, Toh S, Guo J, Hernán MA, Iturralde E, Jastreboff A, Lewis KH, Lund JL, Maciejewski ML, McCoy RG, McTigue KM, Narain K, Wee CC, Osganian SK, Hales C Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop 2026 Jun 30 doi: 10.7326/ANNALS-26-00202. Epub 2026-06-30. PubMed
Arterburn D, Curtis LH, Toh S, Bradley MC, D'Alessio D, Duchovny N, Hines D, Narain K, Parekh A, Skinner A, Wee CC, Wong JB, Wright DR, Osganian SK, Hales C Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop 2026 Jun 30 doi: 10.7326/ANNALS-25-05468. Epub 2026-06-30. PubMed
David E. Arterburn, MD, MPHSenior Investigator |
Allen Cheadle, PhDSenior Investigator, KPWHRI; Senior Research Associate, CCHE |
Andrea J. Cook, PhDSenior Biostatistics Investigator |
Maricela Cruz, PhDAssociate Biostatistics Investigator |
Nicole M. Gatto, PhD, MPHPrincipal Collaborative Scientist |
Beverly B. Green, MD, MPHSenior Investigator |
Mikael Anne Greenwood-Hickman, MPHSenior Collaborative Scientist |
Paula Lozano, MD, MPHSenior Investigator; Director, ACT Center |
Dori E. Rosenberg, PhD, MPHSenior Investigator |
Gregory E. Simon, MD, MPHSenior Investigator |